| Patents for G01N 33 - Investigating or analysing materials by specific methods not covered by groups (393,632) |
|---|
| 12/22/2005 | US20050282229 Methods and device for analyte characterization |
| 12/22/2005 | US20050282228 Methods and compositions for activating or inhibiting vegf-d and vegf-c |
| 12/22/2005 | US20050282227 Treatment discovery based on CGH analysis |
| 12/22/2005 | US20050282225 Quantitative binding assays using green fluorescent protein as a label |
| 12/22/2005 | US20050282224 Method for carrying out a biochemical protocol in continuous flow in a microreactor |
| 12/22/2005 | US20050282223 TR3-specific binding agents and methods for their use |
| 12/22/2005 | US20050282220 Microparticle-based methods and systems and applications thereof |
| 12/22/2005 | US20050282219 Analyzing the identification and the concentration of particular target analytes; biological and chemical assays, receptor binding assay; bioassay of proteins, nucleic acids, peptide nucleic acids, biological cells, microorganisms |
| 12/22/2005 | US20050282218 Microparticle-based methods and systems and applications thereof |
| 12/22/2005 | US20050282217 Using TR10 polypeptide, which is a member of the tumor necrosis factor (TNF) receptor superfamily for inhibiting apoptosis associated with HIV infection |
| 12/22/2005 | US20050282216 Purified polypeptides having IL-13 receptor activity |
| 12/22/2005 | US20050282205 GLUT5 transporters expressed in cancer cells |
| 12/22/2005 | US20050282204 Microarray substrate having patterned thin layer and microarray comprising the same, and methods of producing the microarray substrate and the microarray |
| 12/22/2005 | US20050282201 Cell-based detection and differentiation of lung cancer |
| 12/22/2005 | US20050282199 Method to predict prostate cancer |
| 12/22/2005 | US20050282197 Interpreting DNA |
| 12/22/2005 | US20050282191 Antibody or fragment that binds immunospecifically to a polypeptide; diagnosing and treatment of testicular cancer; spermatid-specific thioredoxin-3 (Sptrx-3) enzyme is used as a fertility marker; biodrugs |
| 12/22/2005 | US20050282187 Reagents and methods useful for detecting diseases of the urinary tract |
| 12/22/2005 | US20050282185 Methods for detecting DNA originating from different individuals |
| 12/22/2005 | US20050282182 Reaction vessel and reaction apparatus comprising three-dimensional particle array |
| 12/22/2005 | US20050282181 Methods for identifying functional antibodies |
| 12/22/2005 | US20050282179 Biomarkers for interferon-alpha response in hepatitis C virus infected patients |
| 12/22/2005 | US20050282173 Single molecule fluorescence assay |
| 12/22/2005 | US20050282172 used in proteomics, wherein the systems and methods are highly specific and sensitive, and easily adapted to automation; immunoglobulins |
| 12/22/2005 | US20050282168 Cell surface molecules as markers and therapeutic agents against kidney cancers |
| 12/22/2005 | US20050282165 Diagnosis of Carcinoma Using RAIG1 Polypeptides |
| 12/22/2005 | US20050282161 Novel phospholipase a2 and gene thereof |
| 12/22/2005 | US20050282157 Using oligonucleotide and peptide nucleic acid oligomers for use as diagnostic tool in monitoring cytosine methylation; detecting cell proliferative, inflammatory, connective, bone, nervous system and cardiovascular disorders |
| 12/22/2005 | US20050282154 Angiotensin-converting enzyme-2 as a receptor for the SARS coronavirus |
| 12/22/2005 | US20050282152 Drug testing with bio-artificial organ slices including for example those derived from liver |
| 12/22/2005 | US20050282150 Identifying an inhibitor of cyclin E2 polypeptide/cyclic-dependent kinase-2 complex formation by allowing a cyclin E2 polypeptide having a specific sequence and cdk2 to spontaneously associate to form a cyclin E2 polypeptide/cdk2 complex; adding test compound; and assaying for a decrease in complex |
| 12/22/2005 | US20050282149 Closed-loop electrical stimulation system for cell cultures |
| 12/22/2005 | US20050282148 permit the assessment of agents without administration to subjects; using the artificial immune system of the invention for evaluating the potential reaction of a diseased animal to an agent |
| 12/22/2005 | US20050282146 Methods to predict additional nodal metastases in breast cancer patients |
| 12/22/2005 | US20050282145 Method for identifying anti-neoplastic compounds |
| 12/22/2005 | US20050281834 Altered peptide ligands |
| 12/22/2005 | US20050281833 Polysaccharide conjugates of biomolecules |
| 12/22/2005 | US20050281832 Methods of enhancing immune response in the intradermal compartment and compounds useful thereof |
| 12/22/2005 | US20050281830 Detection, prevention, and treatment systems for anthrax |
| 12/22/2005 | US20050281827 Trypanosome derived apoptotic factors (TAF) |
| 12/22/2005 | US20050281812 Antibodies to insulin-like growth factor I receptor |
| 12/22/2005 | US20050281805 Targeted therapeutic proteins |
| 12/22/2005 | US20050281745 Stable isotope based dynamic metabolic profiling of living organisms for characterization of metabolic diseases, drug testing and drug development |
| 12/22/2005 | US20050281743 Cancer associated protein phosphatases and their uses |
| 12/22/2005 | US20050281738 Method and means for detecting inflammatory processes |
| 12/22/2005 | US20050281707 clinical specimen processing apparatus and clinical specimen processing system which can be connected to a maintenance management device over a network;capable of recognizing whether or not an apparatus is in an operation tolerance limit condition of the apparatus without affecting the sample processing |
| 12/22/2005 | US20050281706 Moisture-proof, airtight dispenser for both storing and dispensing several flattened articles such as diagnostic test strips; dispenser includes a novel pivotable housing that a user need merely grab and squeeze to eject a test strip |
| 12/22/2005 | US20050280180 Method for making holder |
| 12/22/2005 | US20050279987 Nanostructure sensor device with polymer recognition layer |
| 12/22/2005 | US20050279925 Microfluidic system |
| 12/22/2005 | US20050279647 System and method for coding information on a biosensor test strip |
| 12/22/2005 | US20050279634 Instrument and system for pharmacologic measurement and well vessel used therein |
| 12/22/2005 | US20050279631 System and method for quality assurance of a biosensor test strip |
| 12/22/2005 | US20050279183 Device for performing measurements and/or taking samples in molten metals |
| 12/22/2005 | US20050279178 Method, apparatus and system for monitoring hardening and forecasting strength of cementitious material |
| 12/22/2005 | US20050279156 Diesel oxidation catalyst efficiency diagnostic method |
| 12/22/2005 | US20050278945 Small volume in vitro analyte sensor |
| 12/22/2005 | DE4135486B4 Verfahren zur Messung eines auf ein textiles Substrat aufgetragenen Hilfsmittels A method for measuring a applied to a textile substrate aid |
| 12/22/2005 | DE202005014449U1 Human/animal body tissue examining device has retaining mechanism for direct mounting of camera on body and having port for attachment at body, by negative pressure, so that camera is moved together with tissue during movement of tissue |
| 12/22/2005 | DE10360786B4 Analysehandgerät The handheld analysis device |
| 12/22/2005 | DE10344545B4 Genetisch modifiziertes Kapsidprotein des Beak and Feather Disease Virus Genetically modified capsid protein of the Beak and Feather Disease Virus |
| 12/22/2005 | DE10326035B4 Verfahren zur adaptiven Fehlererkennung auf einer strukturierten Oberfläche Method for adaptive error detection on a textured surface |
| 12/22/2005 | DE102005019760A1 Spinning machine with drawing mechanism for fibrous band of e.g. cotton or polyester, produces spectrograms and diagrams from sensor indications to locate sources of faults |
| 12/22/2005 | DE102004060103A1 Sensor unit for combustible gases, especially suitable for future hydrogen economy, employs heated semiconductor sensor and temperature-sensitive heater |
| 12/22/2005 | DE102004045186A1 Hydratisierte lamellare Phasen oder Liposomen, enthaltend ein Fettmonoamin oder ein kationisches Polymer, das die intrazelluläre Penetration begünstigt, und kosmetische oder pharmazeutische Zusammensetzungen, diese enthaltend, sowie Screeningverfahren nach einer solchen Substanz Hydrated lamellar phases or liposomes, containing a fatty mono-amine or a cationic polymer that promotes intracellular penetration, and cosmetic or pharmaceutical compositions comprising them, as well as screening methods for such substance |
| 12/22/2005 | DE102004028180A1 Calibrating system for thermo-desorption devices comprises a thermo-desorption tube and a vaporizing chamber having a unit for the discontinuous introduction to the calibrating substance |
| 12/22/2005 | DE102004027512A1 Spektroskopischer Gassensor, insbesondere zum Nachweis mindestens einer Gaskomponente in der Umluft, und Verfahren zur Herstellung eines derartigen spektroskopischen Gassensors Spectroscopic gas sensor, in particular for detecting at least one gas component in the circulating air, and methods for producing such spectroscopic gas sensor |
| 12/22/2005 | DE102004025780A1 Verfahren zur Anti-Limulus-Faktoren-unabhängigen Bestimmung der Lipopolysaccharid- und/oder Lipid-A- und/oder Glukan-Reaktivität, dafür geeignetes Testsystem sowie dessen Verwendung A method for anti-Limulus factors-independent determination of lipopolysaccharide and / or lipid-A and / or glucan-reactivity, but suitable test system and its use |
| 12/22/2005 | DE102004025580A1 Sensor-Anordnung, Sensor-Array und Verfahren zum Herstellen einer Sensor-Anordnung Sensor arrangement, the sensor array and method of manufacturing a sensor arrangement |
| 12/22/2005 | DE10120797B4 Verfahren zur Analyse von Nukleinsäureketten A process for the analysis of nucleic acid chains |
| 12/22/2005 | CA2573551A1 Method for detecting a change in the conformational or energetic state of a molecular species |
| 12/22/2005 | CA2573430A1 Anti-perp antibody |
| 12/22/2005 | CA2570053A1 Markers for atherosclerosis |
| 12/22/2005 | CA2569788A1 Tumor specific antibody |
| 12/22/2005 | CA2569620A1 Method for determining the presence or amount of a silver-labelled species |
| 12/22/2005 | CA2569599A1 Method for the early detection of renal disease and injury |
| 12/22/2005 | CA2569511A1 Methods for identification, and compounds useful for the treatment of degenerative & inflammatory diseases |
| 12/22/2005 | CA2569215A1 Screening method using antibody heavy chains |
| 12/22/2005 | CA2568976A1 Biomarkers for peripheral artery disease |
| 12/22/2005 | CA2568305A1 Insulin-independent, bone morphogenetic protein (bmp)-mediated uptake of blood glucose by peripheral cells and tissues |
| 12/22/2005 | CA2567925A1 Electro-chemical sensor |
| 12/22/2005 | CA2567899A1 Analyte sensors and methods for making and using them |
| 12/22/2005 | CA2567877A1 Polynucleotides encoding acetylcholine-gated chloride channel subunits of caenorhabditis elegans |
| 12/22/2005 | CA2567711A1 System for monitoring physiological characteristics |
| 12/22/2005 | CA2566501A1 Durable hydrophilic mouldable polymer composition, aqueous fluid channels based on said composition, microfluidic system incorporating said channels and method for the production thereof |
| 12/22/2005 | CA2565310A1 Fluid monitoring systems and methods with data communication to interested parties |
| 12/22/2005 | CA2565294A1 Identification of antibody-producing cells |
| 12/22/2005 | CA2565124A1 Peptide capable of altering tubulin polymerization and use thereof for inhibiting cell proliferation |
| 12/22/2005 | CA2565114A1 Use of ferrofluids for phenotyping blood and related applications |
| 12/21/2005 | EP1607898A2 A bioinformatics system for functional proteomics modelling |
| 12/21/2005 | EP1607746A2 Clinical specimen processing apparatus and clinical specimen processing system |
| 12/21/2005 | EP1607745A2 Ligand for G-protein coupled receptor FPRL2 and uses thereof |
| 12/21/2005 | EP1607744A2 Treatment of diseases involving cyst formation with combinations comprising a PTBR agonist |
| 12/21/2005 | EP1607743A1 Silane molecules with pre-activated and protein-resistant functionalities and silane films comprising such molecules |
| 12/21/2005 | EP1607742A1 Latex reagent for adiponectin analysis and method of adiponectin analysis |
| 12/21/2005 | EP1607741A1 Test paper and porous membrane |
| 12/21/2005 | EP1607740A1 Method of lipoprotein analysis and analytical program |
| 12/21/2005 | EP1607737A1 Device and method for detection and measurement of nucleic acid strands in solution |
| 12/21/2005 | EP1607481A1 Engineered protein kinases which can utilize modified nucleotide triphosphate substrates |
| 12/21/2005 | EP1607480A2 Method for synthesizing DNA |